You are now leaving GSK’s website

You are now leaving a GSK Website. By clicking this link, you will be taken to a website that is not owned or controlled by GSK, and GSK is not responsible for the content provided on that site

Continue

Go back

Havrix

Havrix is indicated for active immunisation against hepatitis A virus infection. 12

References:

  1. Havrix International Prescrbing Information Version number: GDS012/IPI08/ Date of issue: 15/Sept/2015 2015 GSK group of companies
  2. World Health Organization. Immunization, Vaccines and Biologicals: Hepatitis A. WHO; October 2015. Available from: http://www.who.int/immunization/diseases/hepatitisA/en/ [accessed December 2017].

Havrix is a registered trade mark of the GlaxoSmithKline group of companies